G25.82

🧬ICD-10 CM G25.82 - Stiff-man syndrome

Overview

ICD-10 CM G25.82 classifies Stiff-Man Syndrome (SMS), also commonly referred to as Stiff Person Syndrome (SPS). This is a rare, progressive neurological disorder characterized by fluctuating muscle rigidity and painful spasms primarily affecting the axial muscles and proximal limbs [1]. The condition is believed to be autoimmune in nature, often associated with antibodies against glutamic acid decarboxylase (GAD65) [6].

Accurate coding of G25.82 is essential for documenting this rare condition, supporting access to specialized treatments (including immunotherapy), and capturing the complexity of care required for patients with this disabling disorder [5].

Code Breakdown

The structure of G25.82 follows the ICD-10-CM taxonomy:

Segment	Value	Description
Category	G25	Other extrapyramidal and movement disorders
Subcategory	G25.8	Other specified extrapyramidal and movement disorders
Extension	2	Stiff-man syndrome

Clinical Definition

Stiff-Man Syndrome is a rare neuroimmunological condition characterized by severe and progressive rigidity and stiffness of truncal and proximal muscles [9]. Patients present with exaggerated stimulus-sensitive spasms, axial muscle stiffness, hyperlordotic posture, increased muscle tone, and hyperreflexia [5]. The condition can significantly impair mobility and quality of life [4].

Synonyms and Alternative Names

• Stiff Person Syndrome (SPS)
• Stiff-Person Spectrum Disorder (SPSD)
• Moersch-Woltman Syndrome (historical eponym)
• Stiff Man Syndrome (SMS)
• Spasticity

Coding Guidelines

Includes

• Stiff-man syndrome.
• Stiff person syndrome.
• Stiff-man syndrome variants (when documented as part of the spectrum).
• Progressive fluctuating rigidity of axial and limb muscles associated with this condition.

Excludes

• Other Movement Disorders: G25.89 (Other specified extrapyramidal and movement disorders) - if a different specific disorder is documented.
• Dystonia: G24.- (If dystonia is the primary diagnosis without SPS features).
• Tetanus: A35 (If muscle rigidity is due to tetanus infection).
• Strychnine Poisoning: T65.83 (If rigidity is due to toxin exposure).
• Malignant Hyperthermia: G84.82 (If rigidity is associated with anesthetic reaction).
• Parkinsonism: G20 or G21.- (If parkinsonian features dominate without SPS characteristics).
• Spasticity: G81.- or G82.- (If spasticity is due to other neurological conditions like stroke or spinal cord injury).

Use of Additional Codes

G25.82 may be coded with additional codes to fully capture the clinical picture:

• Diabetes Mellitus Type 1: E10.- (SPS is often associated with other autoimmune conditions including Type 1 diabetes).
• Thyroid Disorders: E05.- or E06.- (Autoimmune thyroid disease is commonly comorbid).
• Anxiety/Phobia: F41.- (Patients often develop anxiety related to spasms and falls).
• GAD65 Antibody Positive: If documented, may support the diagnosis (no specific ICD-10 code; document in medical record).
• Paraneoplastic Syndrome: G13.0 (If SPS is paraneoplastic in nature, associated with underlying malignancy).
• Underlying Malignancy: If paraneoplastic, code the underlying cancer (e.g., breast, lung, lymphoma).

Paraneoplastic Consideration

Approximately 5-10% of Stiff Person Syndrome cases are paraneoplastic, associated with underlying malignancies such as breast cancer, small cell lung cancer, or lymphoma . If paraneoplastic etiology is suspected or confirmed, code both G25.82 and the underlying malignancy.

Risk Adjustment (HCC)

Hierarchical Condition Category (HCC) status determines impact on risk adjustment scores for Medicare Advantage and ACA plans.

• HCC Status: No ^{CMS-HCC V28}
• RAF Impact: This code does not directly contribute to the Risk Adjustment Factor (RAF) score under the current CMS-HCC V28 model.
• Clinical Relevance: While not an HCC, this is a rare, high-cost condition requiring expensive treatments (IVIG, rituximab, plasma exchange) and frequent specialist care. It may trigger care management programs and prior authorization requirements.

Inpatient Impact (MS-DRG)

In the inpatient setting, G25.82 influences the Medicare Severity Diagnosis Related Group (MS-DRG) assignment.

• CC/MCC Status: Non-CC (Not a Complication/Comorbidity) ^{CMS MS-DRG v42}
• Impact: This code generally does not shift a DRG to a higher severity tier on its own. However, it supports medical necessity for admissions related to severe spasms, respiratory compromise, or initiation of immunotherapy.
• POA Indicator: Present on Admission (POA) reporting is required for inpatient claims. Given the chronic nature of this condition, it is typically marked Y (Present on Admission).

Code Tree

Chapter 6: Diseases of the Nervous System (G00-G99)
└── Extrapyramidal and movement disorders (G20-G26)
    └── Other extrapyramidal and movement disorders (G25)
        └── Other specified extrapyramidal and movement disorders (G25.8)
            └── G25.81 (Restless legs syndrome)
            └── G25.82 (Stiff-man syndrome)
            └── G25.89 (Other specified extrapyramidal and movement disorders)

Clinical Coding Examples

Example 1: Classic SPS Diagnosis

Scenario: A 45-year-old female presents with progressive trunk stiffness and painful spasms triggered by sudden movements or emotional stress. GAD65 antibodies are positive. Neurologist diagnoses Stiff Person Syndrome. Coding:

• Primary: G25.82
• Secondary: E10.9 (if Type 1 diabetes is also present)

Example 2: Paraneoplastic SPS

Scenario: Patient diagnosed with Stiff Person Syndrome. Workup reveals underlying breast cancer. Provider documents paraneoplastic stiff person syndrome. Coding:

• Primary: C50.919 (Malignant neoplasm of unspecified site of unspecified female breast) - if cancer is the reason for admission
• Secondary: G25.82
• Additional: G13.0 (Paraneoplastic syndrome on nervous system)

Example 3: SPS with Anxiety

Scenario: Patient with known Stiff Person Syndrome presents with increased anxiety related to fear of falling due to spasms. Coding:

• Primary: G25.82
• Secondary: F41.9 (Anxiety disorder, unspecified)

Example 4: SPS Variant (Stiff Limb Syndrome)

Scenario: Patient presents with stiffness and spasms limited to one limb. Provider documents Stiff Limb Syndrome (a variant of SPS). Coding:

• Primary: G25.82 (Stiff-man syndrome encompasses spectrum variants)
• Note: There is no separate code for Stiff Limb Syndrome; G25.82 is appropriate for spectrum disorders.

Revenue Cycle Considerations

• wRVU: Not Applicable. ICD-10-CM codes do not have work Relative Value Units. wRVUs are assigned to CPT/HCPCS procedure codes.
• Assistant Payable: Not Applicable. This attribute applies to surgical CPT codes.
• Denial Risk: Moderate to High. Due to the rarity of this condition, payers may request additional documentation to support medical necessity of treatments (IVIG, baclofen pumps, etc.).
• Prior Authorization: Treatments for SPS (IVIG, rituximab, intrathecal baclofen) typically require extensive prior authorization with supporting documentation.
• Query Opportunity: If documentation states “muscle rigidity” or “spasms” without specifying Stiff Person Syndrome, and clinical indicators (GAD65 antibodies, classic presentation) are present, a CDI query is recommended.

Treatment Considerations (Documentation Support)

First-line treatment for Stiff Person Syndrome focuses on symptom management with GABA-ergic medications like diazepam and baclofen. Additional therapies may include:

• Immunotherapy: IVIG, rituximab, plasma exchange
• Muscle Relaxants: Baclofen (oral or intrathecal pump), benzodiazepines
• Physical Therapy: To maintain mobility and prevent contractures
• Anticonvulsants: Gabapentin, levetiracetam, valproic acid

Documentation should support the medical necessity of these treatments when billing.

Related Codes

• G25.81: Restless legs syndrome
• G25.89: Other specified extrapyramidal and movement disorders
• G24.9: Dystonia, unspecified
• G13.0: Paraneoplastic syndrome on nervous system
• E10.9: Type 1 diabetes mellitus without complications
• F41.9: Anxiety disorder, unspecified
• G82.50: Quadriplegia, unspecified (if severe complications develop)

Diagnostic Criteria Notes

Suggested diagnostic criteria for Stiff Person Spectrum Disorder include [8]:

• Clinical Symptoms (1 of 2):
  • Stiffness (axial regions, limbs, or both)
  • Episodic spasms (axial regions, limbs, or both)
• Antibody Testing: GAD65 antibodies or other SPS-associated antibodies
• EMG Findings: Continuous motor unit activity in affected muscles
• Response to Treatment: Improvement with benzodiazepines or immunotherapy